Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

QRxPharma Ltd

+ Add to Watchlist

QRXPY:US

0.0500 USD 0.0199 66.11%

As of 20:10:04 ET on 05/26/2015.

Snapshot for QRxPharma Ltd (QRXPY)

Open: 0.0300 Day's Range: 0.0300 - 0.0500 Volume: 917
Previous Close: 0.0301 52wk Range: 0.0300 - 0.4920 1-Yr Rtn: -88.37%

Stock Chart for QRXPY

No chart data available.
  • QRXPY:US 0.0500
  • 1D
  • 1M
  • 1Y
0.0301
Interactive QRXPY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for QRXPY

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 1.64
Shares Outstanding (M) 32.84
30 Day Average Volume 1,156
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for QRXPY

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for QRXPY

QRxPharma Limited is a specialty pharmaceutical company developing and commercializing pain therapy products. The Company's preclinical and clinical pipeline includes other technologies in the fields of neurodegenerative disease and venomics.

Edward M RudnicCEO/COOChris J CampbellCFO/Secretary
Beth A BurnsideSenior VP:Regulatory AffairsM Janette DixonVP:Global Business Development
More Company Profile & Key Executives for QRXPY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil